DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling
Author:
Funder
Zhejiang Provincial People's Hospital
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference43 articles.
1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;J Clin Invest,2011
2. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes;Carey;Clin Cancer Res,2007
3. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007
4. Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial;Bardia;J Clin Oncol,2018
5. Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer;Dent;Breast Cancer Res Treat,2021
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Propofol orchestrates long non-coding RNAs in MCF7 cells, unraveling new avenues for breast cancer intervention;European Journal of Medicinal Chemistry Reports;2024-12
2. New evidence for a role of DANCR in cancers: a comprehensive review;Journal of Translational Medicine;2024-06-14
3. HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer;Journal of Ovarian Research;2024-06-08
4. Depression of LncRNA DANCR alleviates tubular injury in diabetic nephropathy by regulating KLF5 through sponge miR-214-5p;BMC Nephrology;2024-04-12
5. Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications;Frontiers in Oncology;2024-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3